David Moore to Risk
This is a "connection" page, showing publications David Moore has written about Risk.
Connection Strength
0,064
-
Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV. Harm Reduct J. 2020 06 11; 17(1):41.
Score: 0,044
-
Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda. AIDS Patient Care STDS. 2008 Oct; 22(10):787-95.
Score: 0,020